Published in JAMA on September 12, 2012
Mannitol Bronchoprovocation Challenge Ancillary Study/ACRN | NCT00585260
Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects. J Allergy Clin Immunol (2013) 1.80
Impact of Age and Sex on Response to Asthma Therapy. Am J Respir Crit Care Med (2015) 1.43
Guidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendations. Lung India (2015) 1.07
Strategies for tailoring asthma treatment in adults. JAMA (2013) 0.96
Strategies for tailoring asthma treatment in adults. JAMA (2013) 0.95
Inhaled corticosteroids in lung diseases. Am J Respir Crit Care Med (2013) 0.91
Changing roles of eosinophils in health and disease. Ann Allergy Asthma Immunol (2014) 0.89
Predictors of asthma control and lung function responsiveness to step 3 therapy in children with uncontrolled asthma. J Allergy Clin Immunol (2013) 0.86
Fractional exhaled nitric oxide for the management of asthma in adults: a systematic review. Eur Respir J (2016) 0.82
P2X7-regulated protection from exacerbations and loss of control is independent of asthma maintenance therapy. Am J Respir Crit Care Med (2012) 0.81
Designing clinical trials to address the needs of childhood and adult asthma: the National Heart, Lung, and Blood Institute's AsthmaNet. J Allergy Clin Immunol (2014) 0.80
Using fractional exhaled nitric oxide (FeNO) to diagnose steroid-responsive disease and guide asthma management in routine care. Clin Transl Allergy (2013) 0.78
Nitric oxide suppresses LPS-induced inflammation in a mouse asthma model by attenuating the interaction of IKK and Hsp90. Exp Biol Med (Maywood) (2014) 0.78
Inhaled corticosteroid dose adjustment in mild persistent asthma. JAMA (2012) 0.75
ACP Journal Club. Physician-, biomarker-, and symptom-based adjustment of inhaled corticosteroids for asthma had similar effects. Ann Intern Med (2013) 0.75
Clinical Utility of Fractional exhaled Nitric Oxide (FeNO) as a Biomarker to Predict Severity of Disease and Response to Inhaled Corticosteroid (ICS) in Asthma Patients. J Clin Diagn Res (2016) 0.75
Emerging issues in pediatric asthma: gaps in EPR-3 guidelines for infants and children. Curr Allergy Asthma Rep (2014) 0.75
Strategies for tailoring asthma treatment in adults--reply. JAMA (2013) 0.75
Bronchial asthma--Issues for the developing world. Indian J Med Res (2015) 0.75
Symptom-based controller therapy: a new paradigm for asthma management. Curr Allergy Asthma Rep (2013) 0.75
Respiratory reviews in asthma 2013. Tuberc Respir Dis (Seoul) (2014) 0.75
Effect of a retinoid X receptor partial agonist on airway inflammation and hyperresponsiveness in a murine model of asthma. Respir Res (2017) 0.75
Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet (2002) 8.57
Long-term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program Research Group. N Engl J Med (2000) 8.32
Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med (2005) 7.61
Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med (2005) 6.96
Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med (2010) 6.19
Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. N Engl J Med (2007) 5.31
Measuring quality of life in asthma. Am Rev Respir Dis (1993) 4.97
Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med (2004) 4.37
Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Lancet (2008) 4.06
Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir Med (2004) 3.96
Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med (1999) 3.22
Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma. Am J Respir Crit Care Med (2004) 2.62
Lower bronchodilator responsiveness in Puerto Rican than in Mexican subjects with asthma. Am J Respir Crit Care Med (2003) 2.39
Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids. J Allergy Clin Immunol (2005) 1.88
Ethnic differences: word descriptors used by African-American and white asthma patients during induced bronchoconstriction. Chest (2000) 1.84
Ethnic differences in perception of lung function: a factor in pediatric asthma disparities? Am J Respir Crit Care Med (2010) 1.36
Adolescents in clinical remission of atopic asthma have elevated exhaled nitric oxide levels and bronchial hyperresponsiveness. Am J Respir Crit Care Med (2000) 1.21
Quadrupling the dose of inhaled corticosteroid to prevent asthma exacerbations: a randomized, double-blind, placebo-controlled, parallel-group clinical trial. Am J Respir Crit Care Med (2009) 1.20
Nocturnal asthma. J Allergy Clin Immunol (2005) 1.11
Biomarkers predicting response to corticosteroid therapy in asthma. Treat Respir Med (2005) 1.02
Prediction of treatment-response to inhaled corticosteroids by mannitol-challenge test in COPD. A proof of concept. Pulm Pharmacol Ther (2004) 1.00
Cumulative association of five genetic variants with prostate cancer. N Engl J Med (2008) 15.34
An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med (2009) 9.38
Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol (2004) 8.70
Azithromycin for prevention of exacerbations of COPD. N Engl J Med (2011) 8.66
The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest (2006) 8.43
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J (2013) 8.39
Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med (2004) 8.39
Lebrikizumab treatment in adults with asthma. N Engl J Med (2011) 8.07
Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med (2005) 7.61
Microarray-based detection and genotyping of viral pathogens. Proc Natl Acad Sci U S A (2002) 7.27
Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med (2009) 7.17
T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med (2009) 7.11
Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. N Engl J Med (2010) 6.51
Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med (2008) 6.35
Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol (2007) 6.33
Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med (2010) 6.19
Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med (2006) 6.10
A chitinase-like protein in the lung and circulation of patients with severe asthma. N Engl J Med (2007) 6.02
Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med (2009) 5.90
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet (2012) 5.82
Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N Engl J Med (2011) 5.61
Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol (2010) 5.55
Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial. Lancet (2011) 5.42
The effect of telithromycin in acute exacerbations of asthma. N Engl J Med (2006) 5.35
Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet (2004) 5.01
Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. J Natl Cancer Inst (2007) 4.85